EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines.

MLA

Bax, Dorine A., et al. “EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 18, Sept. 2009, pp. 5753–61. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-08-3210.

APA

Bax, D. A., Gaspar, N., Little, S. E., Marshall, L., Perryman, L., Regairaz, M., Viana-Pereira, M., Vuononvirta, R., Sharp, S. Y., Reis-Filho, J. S., Stávale, J. N., Al-Sarraj, S., Reis, R. M., Vassal, G., Pearson, A. D. J., Hargrave, D., Ellison, D. W., Workman, P., & Jones, C. (2009). EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(18), 5753–5761. https://doi.org/10.1158/1078-0432.CCR-08-3210

Chicago

Bax, Dorine A, Nathalie Gaspar, Suzanne E Little, Lynley Marshall, Lara Perryman, Marie Regairaz, Marta Viana-Pereira, et al. 2009. “EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15 (18): 5753–61. doi:10.1158/1078-0432.CCR-08-3210.